Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Clinical Trial to Evaluate Immunogenicity,Safety and Protective Effect of Live Attenuated Varicella Vaccine and a Clinical Trial on Antibody Level and Etiology of Varicella Zoster Virus in Zhejiang Province

NCT05460429 is registered in ClinicalTrials.gov with Sinovac (Dalian) Vaccine Technology Co., Ltd. as lead sponsor.

NCT NCT05460429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05460429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Clinical Trial to Evaluate Immunogenicity,Safety and Protective Effect of Live Attenuated Varicella Vaccine and a Clinical Trial on Antibody Level and Etiology of Varicella Zoster Virus in Zhejiang Province
Lead sponsor
Sinovac (Dalian) Vaccine Technology Co., Ltd.
Phase
Phase 4
Overall status
Unknown status
Start date
July 30, 2022
Completion date
May 15, 2023
Enrollment
37,920 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

varicella